Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells.
about
The role of NKT cells in tumor immunityFine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and functionRole of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune responseTreml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 proteinThe dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed settingNanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Distinct requirements for CD1d intracellular transport for development of V(alpha)14 iNKT cells.Differential roles of lung dendritic cell subsets against respiratory virus infectionOrally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in canceriNKT cells suppress the CD8+ T cell response to a murine Burkitt's-like B cell lymphomaGlycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice.Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccineCross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells.Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity.Dendritic cells and vaccine design for sexually-transmitted diseases.Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.Interactions of tumor cells with dendritic cells: balancing immunity and toleranceCharacterization of a novel nonclassical T cell clone with broad reactivity against human renal cell carcinomas.Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.Glycolipid ligands of invariant natural killer T cells as vaccine adjuvantsHarnessing human CD1d restricted T cells for tumor immunity: progress and challenges.Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.Type I natural killer T cells: naturally born for fighting.Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells.Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens.Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.Invariant NKT cells provide innate and adaptive help for B cells.Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.Immunotherapeutic strategies targeting natural killer T cell responses in cancer.Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.An appreciation of Ralph Marvin Steinman (1943–2011).α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95.Cancer immunotherapy: Re-programming cells of the innate and adaptive immune systems.Natural Killer T Cells in Cancer ImmunotherapyMelanoma vaccines and modulation of the immune system in the clinical setting: building from new realities.Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.
P2860
Q24648939-1EA9EF82-3379-4D3A-B5B6-3D76A51E901EQ26830239-0DDCE87E-DCFA-4330-B079-3039282B749CQ26996330-EA9EE62C-798D-4FB3-B1FB-F9333A42D5D8Q28509633-7A0E4316-3A7A-45B4-9473-73373BC262CDQ29618424-59113A44-D35A-4719-BC68-69084F55CAE8Q33509292-A0B51372-815E-4FE5-86FC-F5A06C37FB1CQ33731430-41A5D857-5E85-4A19-9EAF-96CF08744A66Q33838810-A254DC5F-EEE4-43F7-A685-D7172582E75AQ34267746-9AD2D54F-537B-43A5-93D1-59B6C135ABCBQ34374466-4F5F75BD-C0DC-44E2-BD04-EE2C5030E207Q34983932-1F72C806-719B-440D-92E1-0194C8C9C456Q35127172-70581DFD-7DCA-4D8C-B7CA-072A8CB25D14Q35990678-C1A08D7F-014F-4107-A184-D34881E57C5AQ36024310-9B204E5F-FE10-4169-B402-55F7696D1CCDQ36099421-4A2835A4-3920-43DA-A753-FB2C7B7C0DBEQ36228405-6555AAA6-CAFC-4AB7-BE37-F2236E3387FEQ36229067-4D111CDC-7067-44B9-AE03-9C662E4162CAQ36620776-F3391193-CACA-40F3-B8DD-C6EBC6C9DC29Q36681262-D30FB05E-1429-4423-AF56-CAC1D9A81037Q36862410-6A29F18E-6972-4667-9122-64A6443D2D45Q36975749-493C2C09-C50D-480D-83DD-322103B45661Q36984489-1094CFF0-0408-4593-B837-4628A3F8E6B8Q36990616-803F4F6D-C932-4908-AC95-C088A81F2F49Q37187603-F9E0D707-5880-4ADC-B5B4-726257B327DAQ37388427-DDDF8870-5909-48E8-9F35-23397C5CA9A7Q37448957-70D3B47D-1EF9-47B3-B3E4-284FB765A54FQ37728011-485ED9E8-1CBC-427B-9790-1F9BBEBA6BEDQ37750917-400FE8CD-A821-467F-A442-C60BD38516C0Q37822744-DE9B581C-8376-4299-A4FE-90F9A1CDC570Q37824065-95306A0E-1460-4814-9969-03A450F10DADQ38186944-B6DE27EC-439F-4FD3-B7FB-2BF628086327Q38729516-9DAE82E0-B519-4B44-9906-9676AED0FC77Q38890717-3BF5A798-D542-4E5F-8768-FECFF3C12837Q39049093-C524E955-3664-4A70-B4FD-95E6A543E7EEQ40375320-ED72CE23-04A9-4623-8523-75DD4BC0E1F8Q41373553-F0A125A0-E62A-4189-AC7A-23548837E930Q41787420-8824F8A3-20AD-4A6D-B7E3-6272232F8C5EQ42078314-40251A16-7C43-414A-9B4D-4CE0F3FAD105Q42145973-1BF516DA-1663-4E73-83AA-2CF7A9128E42Q47094171-EF4F4637-C4FE-486A-8F80-2200224C9142
P2860
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Innate NKT lymphocytes confer ...... mor-capturing dendritic cells.
@ast
Innate NKT lymphocytes confer ...... mor-capturing dendritic cells.
@en
type
label
Innate NKT lymphocytes confer ...... mor-capturing dendritic cells.
@ast
Innate NKT lymphocytes confer ...... mor-capturing dendritic cells.
@en
prefLabel
Innate NKT lymphocytes confer ...... mor-capturing dendritic cells.
@ast
Innate NKT lymphocytes confer ...... mor-capturing dendritic cells.
@en
P2093
P2860
P356
P1476
Innate NKT lymphocytes confer ...... mor-capturing dendritic cells.
@en
P2093
Anna Charalambous
Anthony Bonito
Jose Mordoh
Juliana Idoyaga
Ralph M Steinman
Rosa Wainstok
Shin-Ichiro Fujii
Xue-Feng Bai
P2860
P304
P356
10.1084/JEM.20050956
P407
P577
2005-12-01T00:00:00Z